GlassScriptPhysician profile
Ayesha Shaik
NPI 1437647401
$15,151.23
in general payments reported to CMS, 2019-2025
6 companies · $4,477 in 2025
The $4,477 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,826 · 2024: $7,848 · 2025: $4,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $9,750 · Travel and Lodging: $3,137 · Food and Beverage: $1,775 · Education: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $9,749.99 |
| Travel and Lodging | $3,137.00 |
| Food and Beverage | $1,774.60 |
| Education | $489.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,242.87 | 2023-2025 | Accolade Sr, Versacross Access Solution |
| Medtronic, INC. | $4,018.07 | 2024-2025 | Micra, Corevalve Evolut R |
| Abbott Laboratories | $2,612.80 | 2023 | Ensite Precision, Ensite, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $147.02 | 2023-2024 | Wainua, Farxiga |
| Biosense Webster, INC. | $110.30 | 2024 | Carto 3 |
| Novo Nordisk INC | $20.17 | 2024 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayesha Shaik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.